Immunovia AB (OSTO:IMMNOV) Days Sales Outstanding : 85.40 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Days Sales Outstanding?

Immunovia AB's average Accounts Receivable for the three months ended in Mar. 2024 was kr0.15 Mil. Immunovia AB's Revenue for the three months ended in Mar. 2024 was kr0.16 Mil. Hence, Immunovia AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 85.40.

The historical rank and industry rank for Immunovia AB's Days Sales Outstanding or its related term are showing as below:

OSTO:IMMNOV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.14 Med: 35.08 Max: 51.8
Current: 51.5

During the past 11 years, Immunovia AB's highest Days Sales Outstanding was 51.80. The lowest was 31.14. And the median was 35.08.

OSTO:IMMNOV's Days Sales Outstanding is ranked better than
76.47% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs OSTO:IMMNOV: 51.50

Immunovia AB's Days Sales Outstanding increased from Mar. 2023 (36.41) to Mar. 2024 (85.40).

Immunovia AB Days Sales Outstanding Historical Data

The historical data trend for Immunovia AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Days Sales Outstanding Chart

Immunovia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

32.81

31.14

51.80

46.23

Immunovia AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															36.41	31.56	23.00	85.40	85.40

Competitive Comparison of Immunovia AB's Days Sales Outstanding

For the Diagnostics & Research subindustry, Immunovia AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunovia AB's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Immunovia AB's Days Sales Outstanding falls into.

Immunovia AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Immunovia AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.253	+	0.146)	/	2 )	/	1.575	*	365
=	0.1995					/	1.575	*	365
=	46.23

Immunovia AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.146	+	0)	/	1 )	/	0.156	*	365 / 4
=	0.146					/	0.156	*	365 / 4
=	85.40

Immunovia AB (OSTO:IMMNOV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Immunovia AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Immunovia AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunovia AB (OSTO:IMMNOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IMMVF:USA

Address

Medicon Village, Scheelevagen 8, Lund, SWE, 223 63

Website

https://www.immunovia.com

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The group's intangible and tangible assets are in Sweden, in the United States and in Germany.

Immunovia AB (OSTO:IMMNOV) Headlines

No Headlines